International Companies

Lilly shares jump on positive results from oral weight-loss drug trial

By Benjamin Chiou

Date: Thursday 17 Apr 2025

(Sharecast News) - Shares in Eli Lilly & Co were set to soar on Wednesday on the back of positive results of a late-stage trial of its weight-loss pill Orforglipron, which is thought to be a needle-free alternative to Novo Nordisk's popular injectable Ozempic drug.
Lilly said a Phase 3 trial...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page